Respostas Clínicas Cochrane
As Respostas Clínicas Cochrane (RCCs) proporcionam um ponto de entrada amigável, digerível e clinicamente focado para as pesquisas rigorosas das revisões sistemáticas Cochrane. Elas são desenvolvidas para serem acionáveis e para respaldar a tomada de decisão no local de atendimento, e foram adicionadas a seções relevantes do texto principal do Best Practice.
- What are the effects of pregabalin add‐on for people with drug‐resistant focal epilepsy?
- For adults with drug‐resistant focal epilepsy, what are the effects of adjunct eslicarbazepine acetate?
- What are the benefits and harms of lamotrigine add-on in adults or children with drug-resistant partial epilepsy?
- What are the effects of rufinamide as an adjunct to conventional antiepileptic drug (AED) therapy for people with refractory epilepsy?
- What are the effects of tiagabine add‐on therapy for people with drug‐resistant focal epilepsy?
- How does levetiracetam compare with other anti‐epileptic drugs in terms of congenital malformations in children?
- Do psychological treatments improve quality of life for people with epilepsy?
- For people with drug‐resistant epilepsy, how do different ketogenic diets compare?
- What are the effects of a ketogenic diet for people with drug‐resistant epilepsy?
- What are the benefits and harms of losigamone add‐on therapy for adults with focal epilepsy?
O uso deste conteúdo está sujeito ao nosso aviso legal